Bioactivity | Indotecan (LMP-400), an indenoisoquinoline derivative, is a potent Topoisomerase I inhibitor, with IC50s of 300, 1200, 560 nM for P388, HCT116, MCF-7 cell lines, respectively. Indotecan prevents the relaxation of supercoiled DNA and can be used for the research of visceral leishmaniasis[1][2]. |
Invitro | Indotecan (48 h) 抑制 L. infantum 前鞭毛体、离体感染的脾细胞和未感染的脾细胞的 IC50 值分别为 0.10 μM,0.10 μM,和 57.16 μM[2]。Indotecan (1.1-90 μM; 30 min) 诱导 TopI-DNA 共价配合物,并抑制 L. infantum 培养物中 DNA 合成[2]。 |
In Vivo | Indotecan (2.5 mg/kg; 腹腔注射每 2 天一次共 15 天) 减轻了内脏利什曼病小鼠的脾脏和肝脏中的寄生负担[2]。 Animal Model: |
Name | Indotecan |
CAS | 915303-09-2 |
Formula | C26H26N2O7 |
Molar Mass | 478.49 |
Appearance | Solid |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | 4°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) |
Reference | [1]. Balaña-Fouce R, et, al. Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis. Antimicrob Agents Chemother. 2012 Oct;56(10):5264-70. [2]. Seol Y, et, al. Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors. Mol Cancer Ther. 2015 Nov;14(11):2552-9. |